Putting a FX on a strong position
Tuesday, May 5th, 2009
Background
CV Technologies, founded in 1992, strives to transform people’s lives to be healthier and happier by focusing on prevention and recovery through the use of evidence-based naturally-derived health products. The Company’s lead product COLD-FX strengthens the immune system and is widely used as a leading over the counter remedy (”OTC”) for helping to prevent and relieve cold and flu infections.
Challenges
Based on the insights from a Level 5 study, the lead strategy consultancy hired to help position the company, the CV management realized the name “CV Technologies” did not convey the organizations rigorous life sciences orientation, or supported plans to leverage their market leading product as they launch new ones.
Solution
Shikatani Lacroix in partnership with Level 5, developed the new name and identity for the corporation. The challenge was to find a name that not only build on the equities of their core brand, Cold-FX while also being able to be registered across the various mediums around the world. Shikitani Lacroix recommended the AFEXA name since it phonetically incorporated the FX distinct portion of the name while allowing the name to be easily pronounced in English, French and Spanish. Based on the approved name direction, Shikatani Lacroix provided a recommended wordmark that could easily be applied to a wide range of applications. The firm was also retained to evolve their current packaging while developing a brand architecture that could create a strong identity platform for future new products.
Results
The new identity is currently being leveraged across all consumer touch-points.








